Links to stories about and by members of the Djavad Mowafaghian Centre for Brain Health from December 2016/January 2017.
You are hereNews & Events
New research from MSFHR trainee Jose Wijnands (PI: Dr. Helen Tremlett) fills knowledge gaps and establishes a baseline for understanding infection risk for people with multiple sclerosis (MS) relative to those without MS.
In order to effectively use brain imaging to diagnose diseases, physicians and other healthcare professionals need to know what they are looking at. New guidelines co-authored by MRI scientist and physicist Dr. Alex Rauscher, published recently in Nature Reviews Neurology, may improve the process of diagnosis for multiple sclerosis (MS).
The mutation was found in two Canadian families that had several members diagnosed with a rapidly progressive type of MS, in which a person’s symptoms steadily worsen and for which there is no effective treatment.
For patients with Parkinson disease (PD), cognitive decline can be one of the most debilitating symptoms of the condition. As many as 80 per cent of people with PD experience some form of cognitive impairment, with up to a quarter of patients presenting symptoms of memory loss or impairment at diagnosis.
Bacteria in the guts of children who had recently developed multiple sclerosis (MS) differed from healthy control children, finds new research from Dr. Helen Tremlett and her University of California research colleagues, including co-PI Dr. Emmanuelle Waubant. These differences were suggestive of a pro-inflammatory environment within the gut bacterial community of the children with MS.
"In Dr. Haas’ lab, we identified the involvement of the transcription factor MEF2 in regulating metaplasticity by accident. The finding was totally unexpected," says Dr. Simon Chen, who completed his PhD in Dr. Kurt Haas’ lab at UBC. Dr.
As 12,000 neurologists descend on Vancouver for the American Academy of Neurology’s 68th annual meeting this week, the Djavad Mowafaghian Centre for Brain Health is poised to make the most of the opportunity to showcase our clinical and scientific leadership in the field.
Three Centre members will be giving talks at plenary sessions the world’s largest gathering of neurologists, taking place at the Vancouver Convention Centre April 15-21:
On April 13, 2016, the World Bank and the World Health Organization will co-host their first-ever high-level meeting on mental health and economic prosperity in Washington, DC. According to the World Bank, the meeting “aims to move mental health from the margins to the mainstream of the global development agenda” and will bring together finance ministers, inter-governmental organizations, and business, academic, and civic leaders to promote critical investments in mental health around the globe.
The UBC Hospital Clinic for Alzheimer Disease and Related Disorders (UBCH CARD) announced this week that Dr. Haakon Nygaard has been appointed to the role of Medical Manager of the clinic. Located within the Djavad Mowafaghian Center for Brain Health at the UBC Hospital, the clinic was under the leadership of Dr. Howard Feldman until his departure from UBC in March.